Molecular histogenesis of posttransplantation lymphoproliferative disorders

Blood

Volumn 102, Issue 10, 2003, Pages 3775-3785

  Capello, Daniela ^b   Cerri, Michaela ^b   Muti, Giuliana ^b   Berra, Eva ^b   Oreste, Pierluigi ^b   Deambrogi, Clara ^b   Rossi, Davide ^b   Dotti, Giampietro ^b   Conconi, Annarita ^b   Viganò, Mario ^b   Magrini, Umberto ^b   Ippoliti, Giovanbattista ^b   Morra, Enrica ^b   Gloghini, Annunziata ^b   Rambaldi, Alessandro ^b   Paulli, Marco ^b   Carbone, Antonino ^b   Gaidano, Gianluca ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; LATENT MEMBRANE PROTEIN 1; MULTIPLE MYELOMA ONCOGENE 1 PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BURKITT LYMPHOMA; CELL SURVIVAL; CHILD; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION; GENE REARRANGEMENT; GERMINAL CENTER; HISTOGENESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOPROLIFERATIVE DISEASE; MALE; NUCLEOTIDE SEQUENCE; ORGAN TRANSPLANTATION; POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC HYPERMUTATION;

EID: 0242493852     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-05-1683     Document Type: Article

References (52)

1. Penn I, Hammon W, Brettscneider L, Starzl TE. Malignant lymphoma in transplantation patients. Transplant Proc. 1969;1:106-112.
2. Greiner T, Armitage JO, Gross TG, Atypical lymphoproliferative diseases. Hematology (Am Soc Hematol Educ Program). 2000:133-146.
3. Harris N, Swerdlow S, Frizzera G, Knowles D, eds. Post-transplant Lymphoproliferative Disorders. Lyon, France: IARC Press; 2001.
4. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
5. Locker J, Nalesnik M. Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol. 1989;135:977-987.
6. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood. 1995;85:552-565.
7. Leblond V, Davi F, Charlotte F, et al. Posttransplant lymphoproliferativce disorders not associated with Epstein-Barr virus: a distinct entity? J Clin Oncol. 1998;16:2052-2059.
8. Dotti G, Fiocchi R, Motta T et al. Epstein-Barr virus negative lymphoproliferative disorders in long-term survivors after heart, kidney, and liver transplant. Transplantation. 2000;69:827-833.
9. Swinnen LJ. Transplantation-related lymphoproliferative disorder: a model for human immunodeficiency virus-related lymphomas. Semin Oncol. 2000;27:402-408.
10. Muti G, Cantoni S, Oreste P, et al. Post-transplant lympoproliferative disorders: improved outcome after clinico-pathologically tailored treatment. Haematologica. 2002;87:67-77.
11. Cesarman E, Chadburn A, Liu YF, Migliazza A, Dalla-Favera R, Knowles DM. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome. Blood. 1998;92:2294-2302.
12. Chadburn A, Chen JM, Hsu DT, et al. The morphologic and molecular genetic categories of posttransplant lymphoproliferative disorders are clinically relevant. Cancer. 1998;82:1978-1987.
13. Müller-Hermelink HK, Greiner A. Molecular analysis of human immunoglobulin heavy chain variable genes (IgVH) in normal and malignant B cells. Am J Pathol. 1998;153:1341-1346.
14. Küppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med. 1999;341:1520-1529.
15. Stevenson FK, Sahota SS, Ottensmeier CH, Zhu D, Forconi F, Hamblin TJ. The occurrence and significance of V gene mutations in B cell-derived human malignancy. Adv Cancer Res. 2001;83:81-116.
16. Pasqualucci L, Migliazza A, Fracchiolla N, et al. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci U S A. 1998; 95:11816-11821.
17. Shen HM, Peters A, Baron B, Zhu X, Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutations of Ig genes. Science. 1998;280:1750-1752.
18. Cattoretti G, Chang C-C, Cechova, C, et al. BCL-6 protein is expressed in germinal-center B cells. Blood, 1995;86:45-53.
19. Falini B, Fizzotti M, Pucciarini A, et al. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood. 2000;95:2084-2092.
20. Carbone A, Gloghini A, Larocca LM, et al. Expression profile of MUM1/IRF-4, BCL-6, and CD138/ syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas. Blood. 2001;97:744-751.
21. Ariatti C, Vivenza D, Capello D, et al. Commonvariable immunodeficiency-related lymphomas associate with mutations and rearrangements of BCL-6: pathogenetic and histogenetic implications. Hum Pathol. 2000;31:871-873.
22. Carbone A, Gloghini A, Capello D, Gaidano G. Genetic pathways and histogenetic models of AIDS-related lymphomas. Eur J Cancer. 2001;37: 1270-1275.
23. Gaidano G, Cerri M, Capello D, et al. Molecular histogenesis of plasmablastic lymphoma of the oral cavity. Br J Haematol. 2002;119:622-628.
24. Timms JM, Bell A, Flavell JR, et al. Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma. Lancet. 2003;361: 217-223.
25. Fais F, Ghiotto F, Hashimoto S, et al. Chronic lymphocytic leukaemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998;102:1515-1525.
26. Fais F, Gaidano G, Capello D, et al. Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas. Leukemia. 1999;13:1093-1099.
27. Küppers R, Zhao M, Hansmann M-L, Rajewsky K. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J. 1993; 12:4955-4967.
28. Capello D, Vitolo U, Pasquaiucci L, et al. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood. 2000;95: 651-659.
29. Klein U, Küppers R, Rajewsky K. Variable gene analysis of B cell subsets derived from a 4-year-old child: somatically mutated memory B cells accumulate in the peripheral blood already at young age. J Exp Med. 1994;180:1383-1393.
30. Chang B, Casali P, The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today. 1994;15:367-373.
31. Lossos IS, Tibshirani N, Narasimhan B, Levy R. The inference of antigen selection on Ig genes. J Immunol 2000;165:5122-5126.
32. Corpet F. Multiple sequence alignment with hierarchical clustering. Nucl Acids Res. 1988;16: 10881-10890.
33. Gaidano G, Pasqualucci L, Capello D, et al. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. Blood. 2003;102:1833-1841.
34. Farner NL, Dörner T, Lipsky PE. Molecular mechanisms and selection influence the generation of the human VλJλ repertoire. J Immunol. 1999;162:2137-2145.
35. Hsu S-M, Raine L, Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol. 1981;75:734-738.
36. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984;32: 219-229.
37. Flenghi L, Ye BH, Fizzotti M, et al. A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells. Am J Pathol. 1995;147:405-411.
38. Wiidenes J, Voojis WC, Clement C, et al. A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Br J Haematol. 1996;94: 318-323.
39. Armitage JM, Kormos RL, Stuart RS, et al. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppressin. J Heart Lung Transplant. 1991;10:877-887.
40. Lossos IS, Okada CY, Tibshirani R, et al. Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. Blood. 2000;95:1797-1803.
41. Brezinschek H-P, Foster SJ, Brezinschek RI, Dörner T, Domiati-Saad R, Lipsky PE. Analysis of the human VH gene repertoire. J Clin Invest. 1997; 99:2488-2501.
42. Kraj P, Rao SP, Glas AM, Hardy RR, Milner ECB, Silberstein LE. The human heavy chain IgV region gene repertoire is biased at all stages of B cell ontogeny, including early pre-B cells. J Immunol. 1997;158:5824-5832.
43. Atkinson MJ, Cowan MJ, Feeney AJ. New alleles of IGKV genes A2 and A18 suggest significant human IGKV locus polymorphism. Immunogenetics. 1996;44:115-120.
44. Paessler M, Kossev P, Tsai D, et al. Expression of SHP-1 phosphatase indicates post-germinal center cell derivation of B-cell posttransplant lymphoproliferative disorders. Lab Invest. 2002;82:1599-1606.
45. Henderson S, Rowe M, Gregory C, et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell. 1991;65:1107-1115.
46. Caldwell RG, Wilson JB, Anderson SJ, Longnecker R. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity. 1998;9:405-411.
47. Longnecker R. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence? Adv Cancer Res. 2000;79:175-200.
48. Portis T, Longnecker R. Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development. J Virol. 2003;77:105-114.
49. 2+/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J. 1997;16:998-1008.
50. Katzenellenbogen RA, Baylin SB, Herman JG. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood. 1999;93:4347-4353.
51. Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001;194:1625-1638.
52. Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001;194:1639-1647.